Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study-Reference-Cited by-同舟云学术

Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study

Published:2022-12 Issue:12 Volume:28 Page:1366-1377
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Evans Kristin A¹,Pollack Michael²,Portillo Edward³,Strange Charlie⁴,Touchette Daniel R⁵,Staresinic Anthony²,Patel Sushma²,Tkacz Joseph⁶,Feigler Norbert²

Affiliation:

1. Real World Data Research and Analytics, Merative, Ann Arbor, MI.

2. BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE.

3. Pharmacy Practice Division, University of Wisconsin-Madison School of Pharmacy.

4. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston.

5. Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois College of Pharmacy, Chicago.

6. Life Sciences, IBM Watson Health, Cambridge, MA, now with Inovalon, Washington DC.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Reference35 articles.

1. Assessment of the Economic Burden of COPD in the U.S.: A Review and Synthesis of the Literature

2. Direct costs of chronic obstructive pulmonary disease among managed care patients

3. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

4. Projecting Long-term Health and Economic Burden of COPD in the United States

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure;Journal of Clinical Medicine;2024-03-12

2. Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study;Respiratory Medicine;2024-02

3. Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study;International Journal of Chronic Obstructive Pulmonary Disease;2023-10

4. GOLD 2023 Update: Implications for Clinical Practice;International Journal of Chronic Obstructive Pulmonary Disease;2023-05